Form 8-K - Current report:
SEC Accession No. 0001558370-22-000516
Filing Date
2022-01-27
Accepted
2022-01-27 16:30:12
Documents
12
Period of Report
2022-01-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20220121x8k.htm   iXBRL 8-K 38701
  Complete submission text file 0001558370-22-000516.txt   156281

Data Files

Seq Description Document Type Size
2 EX-101.SCH glyc-20220121.xsd EX-101.SCH 3397
3 EX-101.LAB glyc-20220121_lab.xml EX-101.LAB 15367
4 EX-101.PRE glyc-20220121_pre.xml EX-101.PRE 10386
6 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20220121x8k_htm.xml XML 4658
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 22563556
SIC: 2834 Pharmaceutical Preparations